文献速递神经介入CTDSA

SWIFT PRIME试验中临床结局与基线CT及CT血管造影表现的相关性

Correlation between Clinical Outcomes and Baseline CT and CT Angiographic Findings in the SWIFT PRIME Trial.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-10-12

该研究基于SWIFT PRIME试验,分析基线CT及CT血管造影表现与血管内治疗结局的关系。主要终点为90天改良Rankin量表评分0-2分。结果显示,基线梗死核心小、侧支循环优秀和早期治疗的患者从血管内治疗中获益最大。

要点

  • 基线ASPECTS 8-10分患者血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为66% vs 41%(率比1.62)。
  • 血栓长度≥8mm患者血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为71% vs 43%(率比1.67)。
  • 侧支循环优秀患者血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为82% vs 28%。

核心结论

  • 血管内治疗在多个亚组中均观察到获益,但基线梗死核心小、侧支循环优秀和早期治疗的患者反应最佳。

研究设计与样本

  • 基于SWIFT PRIME试验的子组分析和分类回归树分析,纳入基线ASPECTS、闭塞部位、血栓长度、侧支循环状态和发病至治疗时间进行分析,主要终点为90天改良Rankin量表评分0-2分。

关键影像表现/征象

  • 基线梗死核心小(ASPECTS 8-10分,n=145)患者接受血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为66% vs 41%(率比1.62)。
  • 基线梗死核心较大(ASPECTS 6-7分,n=44)患者接受血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为42% vs 21%(率比1.98)。
  • 血栓长度≥8mm患者接受血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为71% vs 43%(率比1.67)。
  • 侧支循环无-一般患者血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为33% vs 0%。
  • 侧支循环良好患者血栓切除联合IV tPA与单用IV tPA的90天mRS 0-2分比例为58% vs 44%;侧支循环优秀患者为82% vs 28%。

诊断标准与关键数值

  • 90天改良Rankin量表评分0-2分定义为主要终点良好结局。
  • 基线ASPECTS 8-10分定义为小梗死核心,ASPECTS 6-7分定义为较大梗死核心。
  • 血栓长度≥8mm与血栓切除联合IV tPA的获益相关(71% vs 43%,率比1.67)。
  • 分类回归树分析显示,基线ASPECTS有利、完全/近完全再通(TICI 2b/3)和早期治疗的患者结局最佳(平均mRS 1.35 vs 3.73)。

临床应用与阅片要点

  • 基线ASPECTS 8-10分、侧支循环优秀和早期治疗的患者从血管内治疗中获益最大。
  • 血栓切除联合IV tPA的获益在按闭塞部位分层的所有组中均观察到。
  • 血栓长度≥8mm患者接受血栓切除联合IV tPA的90天mRS 0-2分比例为71% vs 43%(率比1.67)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Patient selection for endovascular therapy remains a great challenge in clinic practice. We sought to determine the effect of baseline CT and angiography on outcomes in the Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial and to identify patients who would benefit from endovascular stroke therapy.

MATERIALS AND METHODS: The primary end point was a 90-day modified Rankin Scale score of 0-2. Subgroup and classification and regression tree analysis was performed on baseline ASPECTS, site of occlusion, clot length, collateral status, and onset-to-treatment time.

RESULTS: Smaller baseline infarct (n = 145) (ASPECTS 8-10) was associated with better outcomes in patients treated with thrombectomy versus IV tPA alone (66% versus 41%; rate ratio, 1.62) compared with patients with larger baseline infarcts (n = 44) (ASPECTS 6-7) (42% versus 21%; rate ratio, 1.98). The benefit of thrombectomy over IV tPA alone did not differ significantly by ASPECTS. Stratification by occlusion location also showed benefit with thrombectomy across all groups. Improved outcomes after thrombectomy occurred in patients with clot lengths of ≥8 mm (71% versus 43%; rate ratio, 1.67). Outcomes stratified by collateral status had a benefit with thrombectomy across all groups: none-fair collaterals (33% versus 0%), good collaterals (58% versus 44%), and excellent collaterals (82% versus 28%). Using a 3-level classification and regression tree analysis, we observed optimal outcomes in patients with favorable baseline ASPECTS, complete/near-complete recanalization (TICI 2b/3), and early treatment (mean mRS, 1.35 versus 3.73), while univariate and multivariate logistic regression showed significantly better results in patients with higher ASPECTS.

CONCLUSIONS: While benefit was seen with endovascular therapy across multiple subgroups, the greatest response was observed in patients with a small baseline core infarct, excellent collaterals, and early treatment.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Jadhav AP, Diener HC, Bonafe A, et al. Correlation between Clinical Outcomes and Baseline CT and CT Angiographic Findings in the SWIFT PRIME Trial. AJNR Am J Neuroradiol. 2017. PMID: 29025724. doi:10.3174/ajnr.A5406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。